ScienceDaily (Mar. 19, 2010) — Researchers from The University of Texas M. D. Anderson Cancer Center report that in a small study of women with advanced or recurrent endometrial cancer, gemcitabine and cisplatin, when used in combination, produced a response rate in fifty percent of patients.

Go to ScienceDaily-New Chemotherapy Combination for details.
Feel good and keep smiling! Pat & Pattie

Leave a Reply